Recent News and Discussions About Aptevo Layoffs
Aptevo Therapeutics Reports 2021 Financial Results and …
https://www.yahoo.com/now/aptevo-therapeutics-reports-2021-financial-120500643.html
Mar 24, 2022 — SEATTLE, WA / ACCESSWIRE / March 24, 2022 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on …
Layoffs, Hiring Freeze Spread Through Tech – The Information
https://www.theinformation.com/articles/layoffs-hiring-freeze-spread-through-tech
May 4, 2022 — We scooped the news today that Cameo laid off a quarter of its workforce, just the latest example of the layoffs spreading through tech.
Chutes & Ladders—Ex-J&J science chief returns to troubled …
https://www.fiercebiotech.com/biotech/chutes-ladders-ex-j-j-science-chief-returns-to-troubled-galapagos-as-ceo
Aptevo Therapeutics Board Chair Fuad El-Hibri will retire April 1, and vice chair John Niederhuber, M.D,. will become chair that day.
Aptevo Therapeutics Inc. – SEC.gov
https://www.sec.gov/Archives/edgar/data/0001671584/000156459020016154/apvo-pre14a_20200527.htm
Aptevo’s Board of Directors is divided into three classes. … retirement, involuntary termination, layoff , death or disability, would retain his or her …
Seattle just got another publicly traded biotech company
https://www.geekwire.com/2016/seattle-just-got-another-publicly-traded-biotech-company/
Aug 2, 2016 — Aptevo focuses on immunotherapy, a method of cancer treatment that uses agents in the immune system—like antibodies—to wipe out cancer cells …
Aptevo Therapeutics Inc APVO Overview – US News Money
https://money.usnews.com/investing/stocks/apvo-aptevo-therapeutics-inc
One mid adult man staying at home and relaxing during lockdown. Investing. 7 Growth Stocks Hit by Layoffs . These seven publicly traded companies recently laid …
Aptevo Therapeutics EPS beats by $0.06, beats on revenue …
https://seekingalpha.com/news/3729583-aptevo-therapeutics-eps-beats-0_06-beats-on-revenue
Aptevo Therapeutics (APVO): Q2 GAAP EPS of -$1.78 beats by $0.06. … Carvana outlines expense reduction plan and layoffs , defends ADESA acquisition.
BRIEF-Aptevo Therapeutics Q1 Loss Per Share $0.63 | Reuters
https://www.reuters.com/article/brief-aptevo-therapeutics-q1-loss-per-sh/brief-aptevo-therapeutics-q1-loss-per-share-0-63-idINASC0A1GS
May 10, 2018 — APTEVO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.
BRIEF-Aptevo Therapeutics and Alligator Bioscience …
https://www.reuters.com/article/brief-aptevo-therapeutics-and-alligator/brief-aptevo-therapeutics-and-alligator-bioscience-announce-plans-to-co-develop-novel-bispecific-antibody-for-tumor-directed-immunotherapy-idUSFWN1KB0UB
Jul 20, 2017 — Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel bispecific antibody for tumor-directed immunotherapy.
Anthrax Vaccine Maker Emergent BioSolutions Lays Off 91 in …
https://www.biospace.com/article/anthrax-vaccine-maker-emergent-biosolutions-lays-off-91-in-michigan-/
Oct 6, 2016 — The layoffs were in manufacturing, quality and engineering departments. … novel oncology and hematology therapeutics, Aptevo Therapeutics.